PapersFlow Research Brief
Skin Diseases and Diabetes
Research Guide
What is Skin Diseases and Diabetes?
Skin Diseases and Diabetes refers to the cluster of dermatological complications and musculoskeletal manifestations associated with diabetes mellitus and obesity, including acanthosis nigricans, granuloma annulare, scleromyxedema, necrobiosis lipoidica, and the immunocompromised district.
This field encompasses 28,256 published works examining how obesity alters skin physiology and contributes to skin disorders linked to diabetes mellitus. Key conditions studied include acanthosis nigricans, granuloma annulare, scleromyxedema, necrobiosis lipoidica, and musculoskeletal disorders. Research highlights cutaneous manifestations such as insulin resistance-related acanthosis nigricans and diabetes-related foot ulceration risks.
Topic Hierarchy
Research Sub-Topics
Acanthosis Nigricans in Diabetes
This sub-topic covers the hyperpigmented velvety plaques as insulin resistance markers in type 2 diabetes and obesity. Researchers study pathogenesis, diagnostic criteria, and associations with metabolic syndrome.
Necrobiosis Lipoidica
This sub-topic investigates yellow-brown atrophic plaques on lower legs linked to diabetes microangiopathy. Researchers explore histopathological features, ulcer complications, and treatment trials.
Granuloma Annulare and Metabolic Disease
This sub-topic examines annular dermal plaques associated with diabetes and dyslipidemia, including localized and generalized forms. Researchers analyze epidemiology, immune mechanisms, and therapeutic responses.
Scleromyxedema Cutaneous Manifestations
This sub-topic focuses on waxy papules and sclerodermoid changes in renal dialysis patients with paraproteinemia. Researchers study mucin deposition, systemic involvement, and links to diabetes.
Obesity-Related Cutaneous Changes
This sub-topic explores acanthosis, striae, and infections altered by obesity's effects on skin barrier and immunity. Researchers investigate biomechanical properties, microbiome shifts, and intervention outcomes.
Why It Matters
Skin diseases linked to diabetes enable early detection and management of metabolic disorders through visible cutaneous signs. Kahn et al. (1976) in "The Syndromes of Insulin Resistance and Acanthosis Nigricans" identified that six patients with acanthosis nigricans exhibited glucose intolerance, hyperinsulinemia, and marked insulin resistance due to decreased insulin receptors on monocytes, linking skin changes directly to diabetes pathophysiology. Veves et al. (1992) in "The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study" demonstrated elevated foot ulceration risk in diabetic patients with high plantar pressures, informing preventive podiatric care in diabetology. These findings support dermatological screening in diabetic populations to mitigate complications like ulcers, which affect mobility and increase amputation risks.
Reading Guide
Where to Start
"The Syndromes of Insulin Resistance and Acanthosis Nigricans" by Kahn et al. (1976), as it provides a foundational clinical description of acanthosis nigricans with direct evidence of insulin resistance from patient studies, serving as an accessible entry to diabetes-skin links.
Key Papers Explained
Kahn et al. (1976) in "The Syndromes of Insulin Resistance and Acanthosis Nigricans" establishes insulin resistance as a core mechanism for acanthosis nigricans, which Love et al. (1991) in "A New Approach to the Classification of Idiopathic Inflammatory Myopathy" builds upon by classifying related inflammatory myopathies with skin involvement. Dalakas and Hohlfeld (2003) in "Polymyositis and dermatomyositis" and Dalakas (2015) in "Inflammatory Muscle Diseases" extend this to detailed pathogenesis of dermatomyositis. Veves et al. (1992) in "The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study" applies similar principles to diabetic foot risks, while Masi et al. (1980) in "Preliminary criteria for the classification of systemic sclerosis (scleroderma)" offers diagnostic frameworks for overlapping sclerotic skin conditions.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research within this 28,256-paper cluster continues to explore obesity's impact on skin physiology and diabetes complications like necrobiosis lipoidica, though no preprints from the last 6 months are available. Frontiers include refining classifications for scleromyxedema and immunocompromised districts based on established works like Cowper et al. (2000).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Preliminary criteria for the classification of systemic sclero... | 1980 | Arthritis & Rheumatism | 4.9K | ✕ |
| 2 | Vitamin D | 1979 | — | 3.8K | ✕ |
| 3 | A RELATION BETWEEN NON-ESTERIFIED FATTY ACIDS IN PLASMA AND TH... | 1956 | Journal of Clinical In... | 3.5K | ✓ |
| 4 | Polymyositis and dermatomyositis | 2003 | The Lancet | 1.4K | ✕ |
| 5 | The Syndromes of Insulin Resistance and Acanthosis Nigricans | 1976 | New England Journal of... | 1.1K | ✕ |
| 6 | A New Approach to the Classification of Idiopathic Inflammator... | 1991 | Medicine | 969 | ✕ |
| 7 | Scleromyxoedema-like cutaneous diseases in renal-dialysis pati... | 2000 | The Lancet | 878 | ✕ |
| 8 | Inflammatory Muscle Diseases | 2015 | New England Journal of... | 734 | ✕ |
| 9 | Perifollicular Xanthomatosis as the Hallmark of Axillary Fox-F... | 2008 | Archives of Dermatology | 716 | ✕ |
| 10 | The risk of foot ulceration in diabetic patients with high foo... | 1992 | Diabetologia | 694 | ✓ |
Frequently Asked Questions
What is acanthosis nigricans in the context of diabetes?
Acanthosis nigricans presents as a cutaneous manifestation associated with insulin resistance in diabetes. Kahn et al. (1976) in "The Syndromes of Insulin Resistance and Acanthosis Nigricans" reported variable glucose intolerance, hyperinsulinemia, and decreased insulin receptors on monocytes in six affected patients. This skin disorder signals underlying metabolic dysfunction in diabetes mellitus.
How does high foot pressure contribute to skin issues in diabetes?
High foot pressure in diabetic patients increases the risk of foot ulceration. Veves et al. (1992) in "The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study" conducted a prospective analysis showing this direct correlation. Such ulcers represent a major dermatological and musculoskeletal complication requiring targeted pressure offloading.
What defines scleromyxedema-like conditions in diabetic or renal patients?
Scleromyxedema-like cutaneous diseases occur in renal-dialysis patients and relate to immunocompromised districts. Cowper et al. (2000) in "Scleromyxoedema-like cutaneous diseases in renal-dialysis patients" documented these manifestations. They connect to broader skin physiology changes in metabolic and renal disorders akin to diabetes complications.
Which classification criteria apply to systemic sclerosis with skin involvement?
Preliminary criteria for systemic sclerosis classification were developed from multicenter studies of early-diagnosed cases. Masi et al. (1980) in "Preliminary criteria for the classification of systemic sclerosis (scleroderma)" compared patients with systemic lupus erythematosus, polymyositis/dermatomyositis, and Raynaud's phenomenon. These criteria aid diagnosis of scleroderma-related skin diseases overlapping with diabetes clusters.
How are inflammatory myopathies linked to skin diseases and diabetes?
Inflammatory muscle diseases like dermatomyositis and polymyositis feature skin manifestations relevant to diabetes-related dermatology. Dalakas and Hohlfeld (2003) in "Polymyositis and dermatomyositis" outlined pathogenesis and treatment. Dalakas (2015) in "Inflammatory Muscle Diseases" summarized dermatomyositis alongside necrotizing autoimmune myositis, tying into musculoskeletal disorders in obesity and diabetes.
Open Research Questions
- ? What specific mechanisms link insulin receptor decreases in acanthosis nigricans to broader diabetes-induced skin barrier dysfunction?
- ? How do high plantar pressures quantitatively predict foot ulceration progression in diabetic cohorts over time?
- ? Can preliminary systemic sclerosis criteria be refined to better differentiate diabetes-associated scleromyxedema from idiopathic forms?
- ? What role does the immunocompromised district play in exacerbating cutaneous infections in obese diabetic patients?
- ? How do inflammatory myopathies like dermatomyositis interact with obesity-altered skin physiology to worsen musculoskeletal outcomes?
Recent Trends
The field maintains a corpus of 28,256 works with no specified 5-year growth rate available.
Established highly cited papers such as Kahn et al. on acanthosis nigricans and Veves et al. (1992) on diabetic foot ulceration continue to dominate citations, with no recent preprints or news coverage reported in the last 12 months.
1976Research Skin Diseases and Diabetes with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Skin Diseases and Diabetes with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers